Form 8-K - Current report:
SEC Accession No. 0000872589-25-000017
Filing Date
2025-08-01
Accepted
2025-08-01 06:49:57
Documents
14
Period of Report
2025-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K regn-20250801.htm   iXBRL 8-K 23459
2 EX-99.1 exhibit991q22025.htm EX-99.1 461148
6 image0a12a.jpg GRAPHIC 7835
  Complete submission text file 0000872589-25-000017.txt   644147

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT regn-20250801.xsd EX-101.SCH 1788
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT regn-20250801_lab.xml EX-101.LAB 21615
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT regn-20250801_pre.xml EX-101.PRE 12512
16 EXTRACTED XBRL INSTANCE DOCUMENT regn-20250801_htm.xml XML 2835
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

EIN.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19034 | Film No.: 251173612
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)